Stop & Shop opens third store in Cranston, R.I.
QUINCY, Mass. — Stop & Shop is opening the doors of its third store in Cranston, R.I., this weekend, the supermarket chain announced Friday.
"We value the relationship we have with our Cranston area customers and community partners and are pleased to open another store to help further serve the community," Stop & Shop New England division president Mark McGowan said.
The new store, which will pursue LEED certification in the coming months, was built with a range of energy-efficient features including:
New DuctSox (fabric duct) ventilation system — a first of its kind use for Stop & Shop — to provide more uniform airflow;
ECM motors in the refrigerated fixtures and walk-in coolers;
Low-mercury energy efficient T5 HO fluorescent light fixtures with occupancy sensors in the storage areas and offices;
LED lights for accent lighting (also in the refrigerated display cases and interior/exterior signage);
An energy management system to monitor the performance of the lighting, refrigeration, and HVAC systems; and
Low flow fixtures in the bathrooms and prep areas to reduce water consumption.
FDA declines to approve GSK vaccine
PHILADELPHIA — The Food and Drug Administration has declined to approve a vaccine developed by GlaxoSmithKline, the drug maker said.
GSK said it received a complete response letter from the FDA for MenHibrix (Hib-MenCY-TT), a vaccine for toddlers ages 6 weeks to 15 months against infection by Neisseria meningitides serogroups C and Y and Haemophilus influenza type b, also known as Hib. The FDA issues a complete response letter when it has finished reviewing an approval application for a drug or vaccine, but questions remain that preclude final approval; the company applying can resubmit once it has addressed the FDA’s questions.
The London-based company said this was the second complete response letter it had received from the FDA with regard to MenHibrix, though it did not specify which issues the agency had raised.
Roche receives FDA approval for new blood-sugar test strips
BASEL, Switzerland — Roche has received approval from the Food and Drug Administration for its new generation of blood-glucose test strips.
Roche said that its Accu-Chek Aviva Plus test strips are maltose-independent test strips that are designed to prevent the interference of maltose on blood-sugar readings, which can occur in rare cases when drugs containing or metabolizing to maltose are parenterally administered.
The Accu-Chek Aviva Plus test strip is cleared for patient self-monitoring of blood glucose and can be used with the Accu-Chek Aviva system.
“We are very pleased to announce that our new product for self-monitoring of blood glucose will also be available for people with diabetes in the U.S.,” Roche Diagnostics COO Daniel O’ Day said. “With its advanced technology and chemistry it is designed to support patients to manage their condition more effectively. This clearance is a significant milestone for our organization — one that will position us well for the clearance of other products in our pipeline.”